The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura.
作者信息
Lippman S M, Lizak G E, Foung S K, Grumet F C
出版信息
West J Med. 1988 Jan;148(1):86-8.
Abstract
摘要
相似文献
1
The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura.
West J Med. 1988 Jan;148(1):86-8.
2
Posttransfusion purpura: the therapeutic value of PlA1-negative platelets.
Transfusion. 1990 Jun;30(5):433-5. doi: 10.1046/j.1537-2995.1990.30590296377.x.
3
Studies on the pathophysiology of posttransfusion purpura.
Blood. 1986 Aug;68(2):347-50.
4
Posttransfusion purpura: conversion of PLA1-negative platelets to the PLA1-positive phenotype by stored plasma is not due to the presence of soluble PLA1 antigen.
Proc Soc Exp Biol Med. 1990 Nov;195(2):192-6. doi: 10.3181/00379727-195-43133.
5
Post-transfusion purpura: case report.
Ann Hematol. 2001 Aug;80(8):488-91. doi: 10.1007/s002770100312.
6
[Posttransfusion purpura caused by ant-Zw b (P1(A2)].
Ugeskr Laeger. 1986 Oct 20;148(43):2769-70.
7
First example of familial posttransfusion purpura in two PlA1-negative sisters.
Transfusion. 1988 Jul-Aug;28(4):326-9. doi: 10.1046/j.1537-2995.1988.28488265259.x.
8
Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka.
Am J Hematol. 1986 Jan;21(1):79-88. doi: 10.1002/ajh.2830210110.
9
Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen(a).
Am J Hematol. 1988 Sep;29(1):38-40. doi: 10.1002/ajh.2830290109.
10
[Effect of anti-HLA-A1 and anti-PLA1 antibodies on the efficacy of platelet transfusion].
Union Med Can. 1984 Jul;113(7):607-9.
本文引用的文献
1
IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY".
J Clin Invest. 1961 Sep;40(9):1597-620. doi: 10.1172/JCI104383.
2
[Post-transfusion purpura. Apropos of a case treated by plasma exchange and transfusion of P1 A1 negative platelets].
Rev Fr Transfus Immunohematol. 1981 Apr;24(2):211-9. doi: 10.1016/s0338-4535(81)80042-6.
3
Post-transfusion purpura: an enigma of alloimmunization.
Am J Hematol. 1980;9(3):331-6. doi: 10.1002/ajh.2830090312.
4
High-dose intravenous immunoglobulin for post-transfusion purpura.
Scand J Haematol. 1983 Nov;31(5):495-500. doi: 10.1111/j.1600-0609.1983.tb01551.x.
5
Detection of platelet antibodies by anti-kappa light chain facilitation of C-FDA (KC-FDA) thrombocytotoxicity.
Hum Immunol. 1983 Dec;8(4):265-71. doi: 10.1016/0198-8859(83)90053-8.
6
Clinical significance of platelet-specific antigens and antibodies.
Prog Clin Biol Res. 1984;149:103-18.
7
Platelet-specific antigen systems and their detection.
Prog Clin Biol Res. 1984;149:79-101.
8
The occurrence and significance of neutrophil antibodies.
Br J Haematol. 1984 Apr;56(4):521-8. doi: 10.1111/j.1365-2141.1984.tb02176.x.
9
A new micromethod for the in vitro detection of antiplatelet antibodies: C-FDA thrombocytotoxicity.
Hum Immunol. 1980 Jul;1(1):87-96. doi: 10.1016/0198-8859(80)90012-9.
10
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates.
Blood. 1975 Nov;46(5):743-50.
Zotero 插件